WAGNER CHARLES F JR (EVP and CFO) received a stock award from VERTEX PHARMACEUTICALS INC / MA
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 2/6/2025ACC: 0000875320-25-000026
Officer· EVP and CFO
Since Apr 2019
+17.38K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
17.38K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10.26K
Price / share
—
Trade value
—
% of position
23.2%
2/4/2025
44.15K→54.41K
Common Stock
Direct
Shares
+7.11K
Price / share
—
Trade value
—
% of position
13.1%
2/4/2025
54.41K→61.53K
Total
Net shares
+17.38K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2025 | A · Award | +10.26K | — | — | 23.2% | 44.15K | 54.41K |
| Common Stock Direct | 2/4/2025 | A · Award | +7.11K | — | — | 13.1% | 54.41K | 61.53K |
| Total | +17.38K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported